Profile data is unavailable for this security.
About the company
Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.
- Revenue in INR (TTM)19.06bn
- Net income in INR2.40bn
- Incorporated2019
- Employees2.16k
- LocationAarti Pharmalabs Ltd2nd Floor, 204Udyog Kshetra, Mulund - Goregaon Link RMUMBAI 400080IndiaIND
- Phone+91 2 269436100
- Fax+91 2 267976660
- Websitehttps://www.aartipharmalabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innova Captab Ltd | 14.97bn | 1.32bn | 40.58bn | 1.95k | 30.66 | -- | 23.06 | 2.71 | 23.13 | 23.13 | 261.52 | -- | -- | -- | -- | 7,676,703.00 | -- | 10.02 | -- | 15.00 | 36.26 | 27.20 | 8.85 | 8.72 | -- | 12.45 | -- | -- | 15.02 | 27.21 | 35.95 | 35.69 | 109.94 | -- |
| Sun Pharma Advanced Research Co Ltd | 595.96m | -2.67bn | 45.61bn | 316.00 | -- | -- | -- | 76.53 | -8.23 | -8.23 | 1.84 | -10.62 | 0.1853 | -- | 6.17 | 1,885,949.00 | -83.02 | -60.53 | -- | -129.98 | 63.91 | 77.17 | -448.02 | -168.34 | -- | -12.16 | 5.79 | -- | -5.00 | -1.35 | 11.55 | -- | -28.16 | -- |
| Zota Health Care Ltd | 4.73bn | -726.58m | 47.30bn | 519.00 | -- | -- | -- | 10.00 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 55.29bn | 515.00 | 29.81 | -- | 26.17 | 7.52 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 64.65bn | 6.86k | 29.83 | -- | 23.33 | 3.11 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 13.42bn | 1.37bn | 66.44bn | 898.00 | 48.41 | 2.73 | 26.20 | 4.95 | 7.02 | 7.02 | 68.61 | 124.61 | 0.4058 | 0.9867 | 3.41 | 14,939,110.00 | 4.15 | 2.02 | 5.14 | 2.61 | 71.63 | 60.07 | 10.23 | 5.17 | 0.7867 | 4.09 | 0.1957 | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 19.06bn | 2.40bn | 69.30bn | 2.16k | 28.90 | 3.39 | 20.80 | 3.64 | 26.45 | 26.45 | 210.27 | 225.75 | 0.6309 | 1.39 | 4.22 | 8,812,209.00 | 7.94 | -- | 10.54 | -- | 51.04 | -- | 12.58 | -- | 0.8706 | 9.62 | 0.2435 | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 71.77bn | 7.54k | 22.64 | 2.28 | 14.87 | 1.75 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 74.81bn | -- | 43.46 | -- | 40.73 | 12.13 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 11.79bn | 3.52bn | 76.76bn | 491.00 | 21.77 | 6.11 | 20.54 | 6.51 | 20.32 | 20.32 | 68.01 | 72.39 | 0.8706 | 2.87 | 4.51 | 24,013,560.00 | 26.02 | -- | 31.72 | -- | 54.32 | -- | 29.89 | -- | 3.29 | 78.01 | 0.0162 | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 81.34bn | 3.30k | 15.90 | -- | 11.17 | 1.72 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 84.74bn | 1.35k | 23.50 | -- | 18.47 | 3.02 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Viyash Scientific Ltd | 21.26bn | 768.08m | 89.43bn | 1.24k | 86.36 | -- | 44.42 | 4.21 | 2.37 | 2.37 | 70.40 | -- | -- | -- | -- | 17,086,170.00 | -- | 0.4014 | -- | 0.6553 | 51.15 | 42.16 | 4.52 | 0.4199 | -- | 3.92 | -- | 995.91 | 13.26 | 5.64 | 160.99 | -20.73 | -0.126 | -- |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 91.26bn | 1.33k | 31.13 | -- | 28.86 | 6.77 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | 6.19bn | 1.54bn | 91.79bn | 3.76k | 59.71 | 25.96 | 51.55 | 14.83 | 12.37 | 12.37 | 49.75 | 28.45 | 1.53 | 4.18 | 7.99 | 1,644,723.00 | 37.92 | 32.29 | 46.06 | 40.74 | 91.31 | 92.07 | 24.86 | 16.78 | 2.14 | 33.36 | 0.231 | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Sanofi India Ltd | 19.33bn | 3.56bn | 94.26bn | 991.00 | 26.45 | -- | 23.94 | 4.88 | 154.71 | 154.71 | 839.09 | -- | -- | -- | -- | 19,500,500.00 | -- | 22.31 | -- | 31.44 | 51.42 | 54.10 | 18.44 | 21.53 | -- | 321.27 | -- | 132.73 | 0.8567 | -8.10 | -13.96 | -5.41 | -13.65 | 1.99 |
Data as of Feb 11 2026. Currency figures normalised to Aarti Pharmalabs Ltd's reporting currency: Indian Rupee INR
5.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.04m | 2.25% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 846.47k | 0.93% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 676.34k | 0.75% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 496.33k | 0.55% |
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 193.76k | 0.21% |
| BlackRock Advisors (UK) Ltd.as of 09 Jan 2026 | 179.22k | 0.20% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 179.18k | 0.20% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 93.32k | 0.10% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 87.69k | 0.10% |
| Taurus Asset Management Co. Ltd.as of 31 Dec 2025 | 72.06k | 0.08% |
More ▼
Data from 30 Sep 2025 - 15 Jan 2026Source: FactSet Research Systems Inc.
